Primary Insulin-like Growth Factor-1 Deficiency

Also known as: Primary insulin like growth factor-1 deficiency

DrugDrug NameDrug Description
DB01277MecaserminA recombinant insulin-like growth factor-1 used for the long-term treatment of growth failure in pediatric patients with primary IGF-1 deficiency or with growth hormone gene deletion due to the development of neutralizing antibodies to GH.
DB14751Mecasermin rinfabateMecasermin rinfabate was approved for treatment of severe primary insulin-like growth factor (IGF) deficiency or in patients with GH gene deletion who have developed antibodies to growth hormone (GH) ....
DrugDrug NamePhaseStatusCount
DB01277MecaserminNot AvailableTerminated1